Tu1802 Impact of Prior Biliary Drainage With Plastic Stents on the Performance of Self-Expanding Metal Stents in Patients Receiving Neoadjuvant Therapy for Pancreatic Cancer

2015 ◽  
Vol 148 (4) ◽  
pp. S-1186
Author(s):  
Brian Ginnebaugh ◽  
Kathryn R. Byrne ◽  
Darren D. Ballard ◽  
Nishchal Kumar ◽  
Susan Tsai ◽  
...  
2018 ◽  
Vol 06 (06) ◽  
pp. E714-E721 ◽  
Author(s):  
Darren Ballard ◽  
Syed Rahman ◽  
Brian Ginnebaugh ◽  
Abdul Khan ◽  
Kulwinder Dua

Abstract Background and study aims Durable biliary drainage is essential during neoadjuvant therapy (NAT) in patients with pancreatic cancer who present with biliary obstruction. Plastic stents (PS) tend to occlude readily, resulting in delay/interruption of treatment. Our aim was to evaluate the safety and efficacy of self-expanding metal stents (SEMS) for biliary drainage in patients receiving NAT for pancreatic cancer. Patients and methods From 2009 to 2014, all consecutive patients with resectable pancreatic cancer at one tertiary center had SEMS placed for biliary drainage before NAT was started. Data on biliary drainage efficacy, stent malfunction rates and procedural adverse events were collected. Results One hundred forty-two consecutive patients with pancreatic cancer (mean age 66 ± 9 SD years; 81 male, 61 female; 67 resectable, 75 borderline resectable) were enrolled. Eight-seven patients (61 %) had prior PS exchanged to SEMS and 55 (39 %) had SEMS placed upfront. Median duration from SEMS placement to the end of NAT/surgery was 111 days (range 44 – 282). During NAT, SEMS malfunction requiring reintervention occurred in 16 patients (11.2 %): tissue ingrowth 11, stent occlusion from food 6, stent migration 3, incomplete expansion 1, “tissue cheese-cutter” effect 1, and cystic duct obstruction 1. On subgroup analysis, no correlation between SEMS malfunction and stage of disease, prior PS, or duration of NAT was found (r2 = 0.05, P = 0.34). Presence of SEMS in situ did not affect pancreaticoduodenectomy. Conclusion SEMS provide safe, effective and durable biliary drainage during NAT for pancreas cancer. Previously placed PS can be exchanged for SEMS. SEMS do not require removal prior to surgery.Meeting presentations: Digestive Disease Week 2015 and 2017


2020 ◽  
Vol 38 (4_suppl) ◽  
pp. 646-646
Author(s):  
Hachem Hachem ◽  
Sanjay S. Reddy ◽  
Jeffrey Tokar ◽  
Eileen O'Halloran ◽  
Jennifer Higa ◽  
...  

646 Background: Multiple studies have shown the superiority of biliary metal compared with plastic stents for pre-operative (preop) biliary drainage in pancreatic cancer (PDAC). Despite the importance of preop cross-sectional imaging, particularly in the era of neoadjuvant treatment, there is no data on the impact of such stents on the quality of preop cross-sectional imaging. We hypothesis, that biliary metal stents negatively impact the accuracy of preop cross-sectional imaging in pancreatic cancer, with unknown impact for the adequacy of surgical candidacy. Methods: Data of all patients undergoing pancreatic resection for PDAC between 1/1/2012 and 1/1/2018 was retrospectively abstracted. Clinical staging based on preop cross-sectional imaging following biliary stent placement (within 2 months prior surgical resection) was compared with the surgical pathology (staging gold standard). Accuracy of clinical and surgical pathology staging was compared. Logistic regression was performed to control for biliary stent type, neoadjuvant treatment and patient baseline characteristics including BMI and type of imaging. Results: 312 patients underwent pancreatic resections. 118 patients required preop biliary drainage in setting of PDAC, including 92 ERCPs of which 83 were successful (46 plastic and 37 metal stents). 76 patients underwent neoadjuvant chemoradiation therapy. Surgical pathology revealed following stages: 0 n = 4, 1A n = 5, 1B n = 8, 2A n = 20, 2B n = 24, 3 n = 1, 4 n = 14. 96% underwent preop CT and 4% MRI pancreas protocol imaging. Exact correlation between clinical and surgical pathology was present in only 48% of cases (57% plastic, 46% metal stent), with 28% of clinical T overstaging, 4% clinical T understaging, 16% clinical N understaging and 4% unable to stage due to artefacts. More importantly, 8% patients were incorrectly staged to be surgical candidates (14% plastic, 6% metal). Controlling for stent type, neoadjuvant treatment and BMI did not impact preop cross-sectional imaging accuracy. Conclusions: Despite their impact on preop cross-imaging biliary metal stents did not negatively impact the accuracy and patient selection for surgical candidacy compared with biliary plastic stents in PDAC.


Gut and Liver ◽  
2020 ◽  
Vol 14 (2) ◽  
pp. 269-273
Author(s):  
Masaki Kuwatani ◽  
Toru Nakamura ◽  
Tsuyoshi Hayashi ◽  
Yasutoshi Kimura ◽  
Michihiro Ono ◽  
...  

2011 ◽  
Vol 56 (12) ◽  
pp. 3678-3684 ◽  
Author(s):  
Ashwani K. Singal ◽  
William A. Ross ◽  
Praveen Guturu ◽  
Gauri R. Varadhachary ◽  
Milind Javle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document